SureCritic Inc – Trademark Portfolio
Entity Type: 03
SureCritic Inc holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include RESCORE, SURECRITIC, REVIEWREACH, and REVIEW ASSURANCE. The owner is based in Seattle, WA.
900 1st Avenue South, Suite 304
Seattle, WA 98134
Showing of trademarks Trademarks
Trademark Classifications
SureCritic Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SureCritic Inc have?
SureCritic Inc has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 3 cancelled.
What trademark classes does SureCritic Inc file in?
SureCritic Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SureCritic Inc's most well-known trademarks?
SureCritic Inc's registered trademark portfolio includes well-known marks such as RESCORE, SURECRITIC, REVIEWREACH, and REVIEW ASSURANCE. These are among 6 currently registered trademarks in the portfolio.
What is SureCritic Inc's trademark registration success rate?
SureCritic Inc has a 55% trademark registration rate, with 6 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.